Publicador de contenidos

Euroleish.net

Control of Leishmaniasis. From bench to bedside and community

Leishmaniasis is a neglected infectious disease and a major public health and veterinary problem that afflicts both developing countries and Europe.

Leishmaniasis control is the topic for this Marie Sklodowska-Curie – Innovative Training Network (ITN, Horizon 2020) coordinated by Dr. Albert Picado from ISGlobal.

The core of the training programme is the fifteen PhD research projects supervised by specialized senior scientists. Additionally, the researchers will benefit from group coaching at regular intervals in a number of retreats. Trainees are hosted by nine centres of excellence for leishmaniasis research located in Europe for three years to conduct research projects aim to lead to a PhD award and a series of high impact scientific publications. Moreover, training secondments are implemented in the worldwide' twenty-two network partners.

The on-going PhD projects include basic, translational and implementation research projects, and this combination allows for challenging interactions within the network. Individual research projects draw from different scientific disciplines (i.e. molecular biology and epidemiology, drug discovery, vector control and immunology). Researchers will be inducted into a large, diverse and global research community with a strong European basis and focused on a common goal, leishmaniasis control.

Project Funder

This project receives funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 642609.

More information

http://www.euroleish.net

Otros proyectos

Ver proyectos pasados

MESA

La Alianza Científica para la Erradicación de la Malaria (MESA) tiene como objetivo avanzar en la ciencia de la erradicación de la malaria.

NHEPACHA

Nuevas Herramientas para el Diagnóstico y la Evaluación del Paciente con Enfermedad de Chagas

Estudio inmunológico de la vacuna RTS,S

Estudio de correlatos de protección frente a la malaria después de la vacunación con RTS,S/AS01E: Una evaluación inmunológica exhaustiva en el ensayo clínico de Fase III, doble ciego, aleatorizado, multicéntrico con un grupo control

GREPIMER

Grup de recerca en patología importada i malaties emergents i re-emergents

TESEO

Nuevos regímenes de quimioterapia y biomarcadores para la enfermedad de Chagas

ASINTMAL

Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults

ADAM

Administración masiva y focal de fármacos antimaláricos para avanzar hacia la eliminación de la malaria en Mozambique: acelerando la implementación de programas y políticas

MULTIPLY

MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention

Science4Pandemics

Citizens engagement digital platform for collective intelligence in pandemics

HIDDENVIVAX

Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria

MENA Migrant Health

Transforming data collection and surveillance to drive migrant health research, care and policy

SexMal

Social affairs and sex in P. falciparum: implications for malaria elimination

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

SMART

Identifying Severe Malaria with a new Aptamer-based Rapid diagnostic Test

MalTransc

Transcriptional regulation of adaptation and developmental decisions in malaria parasites: from epigenetic variation to directed transcriptional responses

GenMoz

P. falciparum genomic intelligence in Mozambique

BOHEMIA

Broad One Health Endectocide-based Malaria Intervention in Africa